Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 3, Number 1—March 1997
Synopsis

Infectious Diseases and Immunity: Special Reference to Major Histocompatibility Complex

Neeloo Singh*Comments to Author , S. Agrawal†, and A.K. Rastogi*
Author affiliations: *Department of Biochemistry, Central Drug Research Institute, Lucknow, India; †Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Main Article

Table 1

Frequency of HLA class II alleles with significant differences between leprosy patients and healthy controls

Healthy controls
 Leprosy patients
HLA alleles N=47
 N=93
N % N % RRa p
DRB1*15 10 21.3 70 75.3 11.3 <0.00001
DRB1*1501 6 12.8 49 52.7 7.6 <0.00001
DRB1*1502 5 10.6 26 27.9 3.2 <0.05
DRB5*0101 6 12.8 49 52.7 7.6 <0.00001
DRB5*0102 5 10.6 26 27.9 3.2 <0.05
DQA1*0102 9 19.1 38 40.9 2.9 <0.05
DQA1*0103 13 27.6 48 51.6 2.8 <0.05
DQB1*0601 8 17.0 56 60.2 7.4 <0.00001
DRB1*0404 5 10.6 0 0.0 0.04 <0.01
DRB1*0701 13 29.8 11 11.8 0.3 <0.05
DRB1*1401 4 8.5 0 0.0 0.005 <0.05
DQB1*0503 16 36.2 14 16.1 0.3 <0.05

aRR = relative risk

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external